- lumiliximab
-
A chimeric monoclonal antibody being investigated for the treatment of chronic lymphocytic leukemia.
Wikipedia foundation.
Wikipedia foundation.
Lumiliximab — 220px Nombre (IUPAC) sistemático Lumiliximab Identificadores Código ATC ? DrugBank … Wikipedia Español
Lumiliximab — drugbox mab source = Chimeric target = CD23 CAS number = ATC prefix = ATC suffix = PubChem = DrugBank = chemical formula = molecular weight = bioavailability = protein bound = metabolism = elimination half life = excretion = pregnancy AU =… … Wikipedia
Daclizumab — ? Monoclonal antibody Type Whole antibody Source Humanized (from mouse) Target CD25 Clinical data Trade names Zenapax AHFS/Drugs.com … Wikipedia
Omalizumab — ? Monoclonal antibody Type Whole antibody Source Humanized (from mouse) Target IgE Fc region … Wikipedia
Natalizumab — ? Monoclonal antibody Type Whole antibody Source Humanized (from mouse) Target alpha 4 integrin Clinical data Trade names Tysabri AHFS/ … Wikipedia
Metelimumab — ? Monoclonal antibody Type Whole antibody Source Human Target TGF beta 1 Clinical data Pregnancy cat. ? Legal status … Wikipedia
Odulimomab — ? Monoclonal antibody Type Whole antibody Source Mouse Target CD11a Clinical data Pregnancy cat. ? Legal status … Wikipedia
Maslimomab — ? Monoclonal antibody Source Mouse Target T cell receptor Clinical data Pregnancy cat. ? Legal status ? … Wikipedia
Visilizumab — ? Monoclonal antibody Type Whole antibody Source Humanized (from mouse) Target CD3 receptor Clinical data Pregnancy cat. ? Legal status … Wikipedia
Mepolizumab — ? Monoclonal antibody Type Whole antibody Source Humanized (from mouse) Target IL 5 Clinical data Pregnancy cat. ? Legal status … Wikipedia